Rankings
▼
Calendar
CYTK
Cytokinetics, Incorporated
$8B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
Gross Profit
$10M
29.8% margin
Operating Income
$8M
23.2% margin
Net Income
$7M
21.6% margin
EPS (Diluted)
$0.16
QoQ Revenue Growth
-43.9%
Cash Flow
Operating Cash Flow
$78M
Free Cash Flow
$77M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$170M
Total Liabilities
$76M
Stockholders' Equity
$94M
Cash & Equivalents
$67M
← FY 2016
All Quarters
Q1 2017 →
CYTK Q4 2016 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
